What’s actually slowing this PC down?
Pick the symptom - the matching free tool is one click away.
iTechGuides is reader-supported. When you buy through links on our site, we may earn an affiliate commission. As an Amazon Associate I earn from qualifying purchases. Learn more
Nanofibre scaffolds are experimental implants designed to guide damaged peripheral nerves as they grow; they do not instantly reconnect nerves. The evidence described here is chiefly from rat studies, not demonstrated patient outcomes, and it does not establish an approved or commercially available treatment for people.
What “reconnect” means in this research
Peripheral nerve injuries can disrupt movement and sensation. A nerve-guidance scaffold is placed at the injury site to support or direct regenerating nerve tissue. Nanofibre materials can be formed as sheets, meshes or conduits; their structure may provide directional guidance, while an added drug or biological matrix may supply local cues.
These implants are not the same as taking a supplement, and the studies do not show that a scaffold restores function immediately. They measure biological growth and functional outcomes over time in specific animal models.
Why the injury model matters
Crush injury: the nerve remains continuous
In a crush model, the nerve is injured but continuity remains. Osaka University reported a biodegradable electrospun sheet containing methylcobalamin (MeCbl), a form of vitamin B12, intended for local placement at an injured nerve. In laboratory testing, the sheet released MeCbl for at least eight weeks. In a rat sciatic-nerve crush model, the report described motor, sensory, nerve-conduction and myelination outcomes. These findings concern local delivery from an implanted sheet, not oral B12 supplementation. Osaka University’s 2017 report
#1 Best Overall
Nerve gap: the scaffold must bridge a defect
A gap model tests whether a conduit can support regeneration across a missing segment, so it is not directly interchangeable with a crush experiment. In a 2021 study, researchers tested electrospun poly(L-lactic acid) (PLLA) conduits in a 5 mm rat sciatic-nerve defect. They varied fibre orientation and whether the conduit contained porcine decellularized nerve matrix hydrogel, and included an autograft comparator. The study in Theranostics
How scaffold designs and results differ
| Study | Model and material | Reported result and limit |
|---|---|---|
| Osaka University, 2017 | Rat sciatic-nerve crush; biodegradable electrospun MeCbl sheet | Reported motor, sensory, nerve-conduction and myelination outcomes. The sheet released MeCbl for at least eight weeks in vitro; this is a laboratory release result, not a human treatment duration. Source |
| NIMS, 2017 | Rat sciatic nerve; very soft biodegradable-plastic mesh with fibres several hundred nanometres in diameter | The institutional release describes regeneration and motor/sensory recovery, with recovery within six weeks. It also says clinical application was being considered or discussed at the time; that historical statement does not establish current availability. Source |
| Zheng et al., 2021 | 5 mm rat sciatic-nerve defect; electrospun PLLA conduits with random or aligned fibres, with or without porcine decellularized nerve matrix hydrogel; autograft comparator | Among the conduit variants, aligned PLLA with 0.25% hydrogel had the strongest reported results. At eight weeks after surgery, its sciatic functional index was comparable to the autograft group; the autograft group had the highest index across the reported two-to-eight-week period. These are rat findings, not evidence of human efficacy. Source |
| Zhan et al., 2012 | 10 mm rat sciatic-nerve gap; self-assembling nanofibre scaffold inside a blood-vessel conduit | The abstract reports axon regeneration across and beyond the gap, plus improvements in measures including reinnervation and functional recovery. It is a distinct animal study and scaffold design. PubMed record |
| UCL Discovery, 2026 | Experimental conduit using oriented polycaprolactone (PCL) nanofibres coated with endothelial-cell-derived matrix | The repository record describes experimental axon-extension and conduit findings for an in-press article. It is emerging research, not clinical validation. Repository record |
The NIMS and Osaka accounts should not be collapsed into one timeline: NIMS’s release says recovery occurred within six weeks, while Osaka’s account of the related study describes axon regeneration at six months after surgery. They are institutional descriptions with different reported time points.
Rank #2
- COMPREHENSIVE NERVE SUPPORT FORMULA: Nerve Support Formula combines powerful ingredients including r alpha lipoic acid, Benfotiamine, and Acetyl L-carnitine to provide targeted nutritional support for nerve health and overall neurological wellness.*
- ESSENTIAL B-VITAMIN COMPLEX: Our premium nerve health supplements feature crucial B vitamins including Vitamin B12, Vitamin B6, and Riboflavin that support healthy nerve function, energy metabolism, and overall neurological health.*
- POTENT CELLULAR SUPPORT: This advanced ala supplement delivers Alpha lipoic acid along with key nutrients that help maintain healthy nerve cells and promote cellular energy production for healthy nerve function.*
- TARGETED SUPPORT FOR HANDS & FEET: Nerve Regen Formula is designed to promote nerve health and help maintain healthy nerve function in the hands and feet, supporting overall comfort and wellness.*
- MADE IN USA: Nerve Regen Formula is manufactured in USA. Our supplement is gluten-free, dairy-free, soy-free, vegan, and non-GMO, crafted with the highest quality standards.
What the evidence does—and does not—show
- It shows experimental promise: researchers have tested different fibre arrangements, materials and local biological cues in animal models.
- It does not establish a treatment for people: the cited evidence includes rat models and an emerging repository-listed study, not demonstrated patient outcomes or a human success rate.
- It does not establish a product patients can buy: these are experimental surgical implants and biomaterials, not consumer nerve-repair products.
- It does not make different injuries equivalent: a crush injury with continuity remaining differs from a defined gap that a conduit must bridge.
For a person with a suspected nerve injury, these findings are not a basis for self-treatment or for substituting supplements for clinical assessment. The studies do not identify an available nanofibre implant or establish when one might become a clinical option.
Quick Recap
Product prices and availability are accurate as of the date/time indicated and are subject to change. Any price and availability information displayed on Amazon at the time of purchase will apply.
